2857 related articles for article (PubMed ID: 6607324)
21. [Antigen retrieval by microwave oven with buffer of citric acid].
Pellicer EM; Sundblad A
Medicina (B Aires); 1994; 54(2):129-32. PubMed ID: 7997128
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
23. Micronucleus formation in human melanoma xenografts following exposure to hyperthermia.
Rofstad EK; Falkvoll KH; Oftedal P
Radiat Environ Biophys; 1984; 23(1):51-60. PubMed ID: 6709827
[TBL] [Abstract][Full Text] [Related]
24. [Transfer factor. Properties and possible therapeutic applications (author's transl)].
Grob PJ; Reymond JF; Häcki MA; Frey-Wettstein M
MMW Munch Med Wochenschr; 1975 Mar; 117(13):517-24. PubMed ID: 805916
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of melanoma pulmonary metastasis by methylxanthines due to decreased invasion and proliferation.
Lentini A; Kleinman HK; Mattioli P; Autuori-Pezzoli V; Nicolini L; Pietrini A; Abbruzzese A; Cardinali M; Beninati S
Melanoma Res; 1998 Apr; 8(2):131-7. PubMed ID: 9610865
[TBL] [Abstract][Full Text] [Related]
26. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
[TBL] [Abstract][Full Text] [Related]
27. Semiquantitative PCR of alpha2 and alpha4 integrin mRNA shows differential response to the transcriptional modulators TGF-beta1 and TPA.
Zhu YH; Vekemans S; Cassiman JJ
Cell Mol Biol (Noisy-le-grand); 1997 Dec; 43(8):1221-6. PubMed ID: 9489948
[TBL] [Abstract][Full Text] [Related]
28. Survival of Cloudman mouse melanoma cells after irradiation by solar wavelengths of light.
Cieszka K; Hill HZ; Xin P; Azure M; Hill GJ; Meyenhofer MF; Boissy RE; Mitchell DL
Pigment Cell Res; 1997 Aug; 10(4):193-200. PubMed ID: 9263325
[TBL] [Abstract][Full Text] [Related]
29. Continuing medical education case study series. An innovative programme for general practitioners on malignant melanoma.
Laidlaw JM; Harden RM; Morris AM
Med Educ; 1996 May; 30(3):226-31. PubMed ID: 8949558
[TBL] [Abstract][Full Text] [Related]
30. Application of interleukin 12 to antitumor cytokine and gene therapy.
Nishimura T; Watanabe K; Yahata T; Ushaku L; Ando K; Kimura M; Saiki I; Uede T; Habu S
Cancer Chemother Pharmacol; 1996; 38 Suppl():S27-34. PubMed ID: 8765412
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of a series of tyrphostins containing nitrothiophene moieties as possible epidermal growth factor receptor tyrosine kinase inhibitors.
Brunton VG; Kelland LR; Lear MJ; Montgomery GJ; Robertson JH; Robins DJ; Queen J; Workman P
Anticancer Drug Des; 1996 Jun; 11(4):265-95. PubMed ID: 8679052
[TBL] [Abstract][Full Text] [Related]
32. Phorbol 12-myristate 13-acetate enhances nm23 gene expression in murine melanocytes but not in syngeneic B16-BL6 melanoma variants.
Huijzer JC; McFarland M; Niles RM; Meadows GG
J Cell Physiol; 1996 Mar; 166(3):487-94. PubMed ID: 8600152
[TBL] [Abstract][Full Text] [Related]
33. Effect of Adriamycin on liposomal muramyl tripeptide's ability to up-regulate monocyte cytokine expression.
Asano T; Fujimaki W; McWatters A; An T; Matsushima K; Kleinerman ES
Cancer Immunol Immunother; 1993 Nov; 37(6):408-11. PubMed ID: 8242665
[TBL] [Abstract][Full Text] [Related]
34. Boronated starburst dendrimer-monoclonal antibody immunoconjugates: evaluation as a potential delivery system for neutron capture therapy.
Barth RF; Adams DM; Soloway AH; Alam F; Darby MV
Bioconjug Chem; 1994; 5(1):58-66. PubMed ID: 8199235
[TBL] [Abstract][Full Text] [Related]
35. Melanoma prevention: is it possible to change a population's behavior in the sun?
Marks R
Pigment Cell Res; 1994 Apr; 7(2):104-6. PubMed ID: 8066015
[TBL] [Abstract][Full Text] [Related]
36. Association between biosynthesis of nitric oxide and changes in immunological and vascular parameters in patients treated with interleukin-2.
Miles D; Thomsen L; Balkwill F; Thavasu P; Moncada S
Eur J Clin Invest; 1994 Apr; 24(4):287-90. PubMed ID: 8050458
[TBL] [Abstract][Full Text] [Related]
37. The use of tumour necrosis factor (TNF) in isolated perfusion: results and side effects. The NCI results.
Fraker DL; Alexander HR
Melanoma Res; 1994 Mar; 4 Suppl 1():27-9. PubMed ID: 8038592
[TBL] [Abstract][Full Text] [Related]
38. Immune-complexes in malignant skin melanoma: quantitation by three methods, purification, and characterization of their non-tumor related constituents.
Borzini P; Del Giudice G; Natali S; Serino G; Nembri P; Manca F; Zanussi C
Boll Ist Sieroter Milan; 1980 Sep; 59(4):366-73. PubMed ID: 7470278
[TBL] [Abstract][Full Text] [Related]
39. Radiation response in vitro of cells from five human malignant melanoma xenografts.
Rofstad EK; Brustad T
Int J Radiat Biol Relat Stud Phys Chem Med; 1981 Dec; 40(6):677-80. PubMed ID: 6978304
[No Abstract] [Full Text] [Related]
40. Surgery in recurrent malignant melanoma.
Karakousis CP; Moore R; Holyoke ED
Cancer; 1983 Oct; 52(7):1342-5. PubMed ID: 6883294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
